Upstream Bio, Inc.
UPB
$25.01
-$3.97-13.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -27.11% | 65.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -27.11% | 65.55% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -27.11% | 65.55% | |||
| SG&A Expenses | -25.30% | 9.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.94% | 39.00% | |||
| Operating Income | 14.69% | -38.53% | |||
| Income Before Tax | 15.56% | -46.56% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.56% | -46.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.56% | -46.56% | |||
| EBIT | 14.69% | -38.53% | |||
| EBITDA | 14.71% | -38.58% | |||
| EPS Basic | 15.81% | -46.15% | |||
| Normalized Basic EPS | 15.80% | -46.12% | |||
| EPS Diluted | 15.81% | -46.15% | |||
| Normalized Diluted EPS | 15.80% | -46.12% | |||
| Average Basic Shares Outstanding | 0.30% | 0.29% | |||
| Average Diluted Shares Outstanding | 0.30% | 0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||